Counterfeit Pharmaceuticals
Counterfeit Pharmaceuticals is a pharmaceutical product that belongs to the category of medical counterfeits, distinguished by its deliberate and unauthorized misrepresentation of identity, source, or composition, including active ingredients, dosage, or manufacturer, thereby posing significant risks to public health and regulatory integrity.
160
Publications
7.4K
Citations
498
Authors
205
Institutions
Publications per year
2017–2026
41
Variants
Counterfeit DrugsFalsified Medical Products
Parents
160
Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle
Kah Seng Lee, Siew Mei Yee, Rahul P. Patel et al. · Frontiers in Pharmacology · 2017 · 440 citations · Full text
1–5 of 160
498
7
h-index
6
h-index
4
h-index
4
h-index
4
h-index
1–5 of 498
205
University of Oxford
Oxford, United Kingdom
5 h-index
13 publications
1.5K citations

Churchill Hospital
Oxford, United Kingdom
5 h-index
16 publications
2.7K citations
Georgia Institute of Technology
Atlanta, United States
5 h-index
19 publications
1.7K citations
Mahosot Hospital
Vientiane, Laos
4 h-index
12 publications
1.4K citations
United States Food and Drug Administration
Silver Spring, United States
4 h-index
13 publications
1.6K citations
American Enterprise Institute
Washington D.C., United States
4 h-index
5 publications
185 citations
Wellcome Trust
London, United Kingdom
4 h-index
24 publications
4.5K citations
Institut Scientifique de Santé Publique
Brussels, Belgium
3 h-index
12 publications
425 citations
1–8 of 205
Repository · 8 publications · 356 citations
8
h-index
7 publications · 334 citations
7
h-index
4 publications · 638 citations
4
h-index
4 publications · 145 citations
4
h-index
3 publications · 116 citations
3
h-index
1–5